Sleep Apnea Device Receives FDA Approval - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Sleep Apnea Device Receives FDA Approval

Randomized trial data support the approval, with sustained improvements in apnea severity observed.

  • By

  • Kathryn Wighton

  • March 19, 2026

  • 2 min

Share

Clinical Scorecard: Sleep Apnea Device Receives FDA Approval

At a Glance

CategoryDetail
ConditionObstructive Sleep Apnea
Key MechanismsProximal hypoglossal nerve stimulation via six electrodes to access airway-controlling muscles.
Target PopulationAdult patients with moderate to severe obstructive sleep apnea who have failed, do not tolerate, or are ineligible for first-line therapies.
Care SettingClinical settings for patients with obstructive sleep apnea.

Key Highlights

  • FDA approved the aura6000 System for hypoglossal nerve stimulation.
  • Indicated for patients with apnea-hypopnea index between 15 and 65.
  • 65% of patients met responder criteria at 12 months.
  • Median apnea-hypopnea index decreased from 34.3 to 11.0 events per hour.
  • Device does not require drug-induced sleep endoscopy prior to implantation.

Guideline-Based Recommendations

Diagnosis

  • Assess apnea-hypopnea index to determine eligibility for treatment.

Management

  • Consider hypoglossal nerve stimulation for patients intolerant to or ineligible for CPAP.

Monitoring & Follow-up

  • Evaluate apnea-hypopnea index and oxygen desaturation index at follow-up.

Risks

  • Monitor for potential complications related to device implantation.

Patient & Prescribing Data

Adults with moderate to severe obstructive sleep apnea.

Customizable titration options available for therapy delivery.

Clinical Best Practices

  • Utilize data from the OSPREY trial to inform treatment decisions.
  • Ensure thorough patient selection based on apnea-hypopnea index.

Related Resources & Content

Original Source(s)

Sleep Apnea Device Receives FDA Approval

  • by Kathryn Wighton

  • March 19, 2026

Related Content

Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.

ACP Ranks Obesity Drug Options

A living clinical guideline outlines a treatment hierarchy for selected pharmacologic therapies in patients with obesity and selected patients with overweight.

Side Effects: Turns Out, Never Mind

Red meat didn't wreck the pancreas. Sauna doesn't do what we thought. Loneliness doesn't accelerate decline. A week of quietly overturned assumptions.